Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved Contrave (naltrexone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE